• Company
• ‘Brilinta’ generic to be released next month
• by Kim, Jin-Gu Oct 25, 2021 05:50am

• Opinion
• [Desk's view] It should also prepare for "With Corona"
• by Chon, Seung-Hyun Oct 25, 2021 05:50am

• Policy
• HIRA “Will improve RSA and prior authorization system”
• by Lee, Hye-Kyung Oct 25, 2021 05:50am

• Opinion
• [Reporter's view] Disclosure of the results of the Committee
• by Eo, Yun-Ho Oct 25, 2021 05:49am

• Company
• Boryung Pharmaceutical acquired Zyprexa's domestic rights
• by Kim, Jin-Gu Oct 25, 2021 05:49am

• Policy
• Domestic approval for Pfizer's Cibinqo (PO) is imminent
• by Lee, Tak-Sun Oct 22, 2021 05:45am

• Policy
• "Annual unused drug returns record ₩2.7 trillion”
• by Lee, Jeong-Hwan Oct 22, 2021 05:45am

• Company
• Supreme court to finally rule on ‘Galvus’ patent dispute
• by Kim, Jin-Gu Oct 22, 2021 05:45am

• Policy
• There are expectations & concerns about ordering research
• by Lee, Jeong-Hwan Oct 22, 2021 05:44am

• Company
• COVID antibody kits are entering the market of clinics
• by Kim, Jin-Gu Oct 22, 2021 05:44am